PTEN and cancer: Below 30 weeks all mice had HGPIN, and among the nine mice examined between 30 and 50 weeks of age, we found similar proportions of focal and more extensive invasive cancer (3 with HGPIN, 4 with focal invasion, and 2 with poorly differentiated adenocarcinoma) to those seen in Pten null mice.